ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder

Am J Health Syst Pharm. 2020 Dec 4;77(24):2114-2132. doi: 10.1093/ajhp/zxaa303.

Abstract

In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Keywords: antipsychotics; schizoaffective disorder; schizophrenia; therapeutic position statement.

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Humans
  • Psychotic Disorders / drug therapy*
  • Schizophrenia / drug therapy*
  • Societies, Pharmaceutical
  • United States

Substances

  • Antipsychotic Agents